NCT04322539 2025-04-04
FRESCO-2
Hutchmed
Phase 3 Completed
Clinical Trials
7 trialsNCT06031376 2023-09-11
Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
Hunan Cancer Hospital
Completed
NCT05025631 2023-04-28
DOFEMCRC
Sichuan University
Phase 2 Completed
NCT05368805 2022-10-06
Fruquintinib DDI Study With P-gp and BCRP Substrates
Hutchmed
Phase 1 Completed
NCT02196688 2020-06-16
Study of Fruquintinib in Patients With Metastatic Colorectal Cancer
Hutchmed
Phase 2 Completed
NCT01975077 2020-02-17
A Phase Ib Study of Fruquintinib in 3rd Line mCRC
Hutchmed
Phase 1/2 Completed
NCT02314819 2020-02-17
FRESCO
Hutchmed
Phase 3 Completed